We have previously shown that gene clusters for biosyntheses of terpentecin and BE-40644, a diterpene antibiotic and a sesquiterpene antibiotic, respectively, were located in the adjacent mevalonate pathway gene clusters. In this study, a mevalonate pathway gene cluster was cloned from Streptomyces sp. strain KO-3988, which was known to produce furaquinocin A, employing a hybridization experiment using a 3-hydroxy-3-methyl glutaryl CoA (HMGCoA) reductase gene, which had been previously cloned from the strain KO-3988, as a probe. By sequencing flanking regions, we found four open reading frames that could encode a putative cytochrome P450 (ORF1), an isoprenoid cyclase (ORF2), an unknown protein (ORF3), and a polyprenyl diphosphate synthase gene (ORF4) in the upstream region of the mevalonate pathway gene cluster, though we did not find any genes related to furaquinocin A biosynthesis. The two ORFs (ORF2 and 4) were expressed as recombinant enzymes in E. coli and used for studies to investigate functions of these products. The ORF4 product was confirmed to be a geranylgeranyl diphosphate (GGDP, C20) synthase. The ORF2 product proved to catalyze a conversion of GGDP into copalyl diphosphate, the first example of an enzyme with this function of prokaryotic origin. These results again showed that actinomycetes possessing the mevalonate pathway usually produce an isoprenoid and that its biosynthetic gene cluster exists in adjacent the mevalonate pathway gene cluster. Streptomyces argenteolus that produce the isoprenoid compounds, pentalenolactone4), brasilicardin A5) and KS505a3), respectively. On the other hand, we have previously showed that both the mevalonate and MEP pathways were operating in some Streptomyces strains such as Kitasatospora griseola (terpentecin producer)6,7), Actinoplanes sp. strain A40644 (BE-40644 producer)7-9), Streptomyces sp. strain CLI90 (naphterpin producer)7,10,11),
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All isoprenoid compounds are derived from the fivecarbon precursors, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP)1,2). In eukaryotes and archaebacteria, IPP is supplied via the mevalonate pathway1,2). On the other hand, IPP is synthesized through the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway in most bacteria, green algae and in the chloroplasts of higher plants3 with or without ME was examined.
The plasmid was also introduced into S. lividans. Analysis of the Metabolite NMR spectra were taken on a JEOL A-500 spectrometer operating at 500MHz for 1H and 125MHz for 13C. cloned from the terpentecin producer15) and BE-40644 producer9), because IPP needed for cell growth was supplied by the mevalonate pathway. This strategy was employed here. As shown in Fig. 2 The mutant DYM1 harboring pWHM3 (vector) cannot grow on the LB plate (A; right), but can grow on the LB plate supplemented with ME (0.01%) (B; right). The DYM1 strain transformed with pFQ-MEV1 carrying the gene cluster for the mevalonate pathway enables growth on the LB plate without ME (+IPTG, 0.1mM) (A; left). genes (ORF4), were suggested to exist in that order (Fig. 1 ). In the terpentecin (diterpene) and BE-40644 (sesquiterpene) producers, polyprenyl diphosphate synthase genes, that is, a GGDP (C20) synthase gene and an FDP (C15) synthase gene, which supply substrates for terpentecin and BE-40644 biosyntheses, respectively, were also located in the region just upstream of the mevalonate pathway gene cluster9,15). Considering that the strain KO-3988 is known to produce furaquinocin A (C10), the ORF4 product was suggested to encode a geranyl diphosphate (C10) synthase. Therefore, the ORF4 product was expressed as a recombinant enzyme and used for in vitro assay to determine the chain length of the product. A plasmid, pFQ-PRENYL1, was constructed to obtain an N-terminal His-tagged recombinant ORF4 product. Expression of the recombinant enzyme in soluble form was confirmed by SDS-PAGE (Fig. 3A ). The expressed protein was then purified and used for an enzyme assay. When the assay was carried out using DMAPP and [1-14C]IPP as substrates, followed by de-phosphorylation of the product, to our surprise, geranylgeraniol (C20) was detected as a major product by TLC analysis (Fig. 3B) . Although additional spots of farnesol (C15) and geraniol (C10) were also detected, we concluded that ORF4 would be a geranylgeranyl diphosphate synthase because the product chain lengths of polyprenyl diphosphate synthase were reported to be modulated by the reaction conditions, such as the concentrations of the substrates and the divalent cations24,25). This result suggested that the ORE1 to 4 would participate in the biosynthesis of a diterpene compound.
Characterization of the ORF2 Product
The ORF4 product was confirmed to be a GGDP synthase as described above. The ORF2 product homologous to isoprenoid cyclases, therefore, was suggested to encode a diterpene cyclase. Diterpene cyclases are classified into two major types with respect to their modes of cyclization26). One type of the reaction is initiated by ionization of GGDP to an allylic carbocation followed by cyclization and deprotonation to an olefin. The other type of the reaction is initiated by protonation at the 14,15-double bond of GGDP. The former class and the latter class of enzymes are known to possess a DDXXD motif and a DXDD motif, respectively, which mediate substrate binding by chelation to a divalent metal ion26). Considering that the ORF2 product is similar to isoprenoid cyclases with DXDD motifs, the ORF2 was assumed to convert GGDP into a cyclized intermediate with the diphosphate group by the protonation-initiated cyclization. To examine this possibility, we overproduced the ORF2 product as a Histagged recombinant protein (Fig. 4A ) and the purified enzyme or heat denatured enzyme was incubated with GGDP. By a reversed-phase HPLC analysis using an ionpair reagent, the formation of a reaction product, which was eluted with a retention time shorter than that of GGDP, was specifically detected in the reaction mixture using the active ORF2 (Fig. 4B) . The peak disappeared when the reaction product was incubated with phosphatase, suggesting that the product had a diphosphate group as expected.
Structure Determination of the Product Formed from GGDP by the ORF2 Product
The molecular formula of the reaction product was Fig. 5 (a) . The remaining connections between C-1 and C-3, C-5 and C-7, and C-9
and C-11 were established by analysis of the COSY spectral data.
The relative stereochemistry of the compound was determined by detailed analysis of NOESY spectral data as shown in Fig. 5 (b) . The angular methyl group at C-10 (C-20) proved to be in axial orientation due to strong NOE with axial methyl protons at C-4 (C-19). The proton at C-5
showed strong NOE with equatorial methyl protons at C-4 establishing its axial orientation. Strong NOE observed between the methyl group at C-10 and the methylene protons at C-11 proved the stereochemistry of the side chain at C-9 to be equatorial. These data established the structure of the compound to be anti-copalyl diphosphate or its enantiomer, ent-copalyl diphosphate, as shown in Fig. 6 .
The proposed structure was supported by comparison of its 13 C-NMR spectral data with those of anti-copalol27 (A) Purified ORF2 product was analyzed on an SDS-PAGE (10%). Proteins were stained with Coomassie brilliant blue R-250. M, molecular mass marker; lane 1, cell free extract of E. coli harboring pQE30 (vector); lane 2. cell free extract of E. coli harboring pFQ-DC1; lane 3, purified His-tagged ORF2 product. (B) Reaction products formed by denatured ORF2 (a) or active ORF2 (b) in the presence of GGDP were analyzed by reverse-phase HPLC using an ion-pair reagent. We had previously shown that terpentecin16) and BE-406449) biosynthetic gene clusters existed in adjacent the mevalonate pathway gene clusters. In this study, the mevalonate pathway gene cluster was cloned from the strain KO-3988, which was known to produce furaquinocin A12), by a hybridization experiment using the HMG-CoA reductase gene, which had previously been cloned from the strain KO-398813), as a probe. We analyzed flanking regions of the cluster to examine whether furaquinocin A biosynthetic genes might be present. As a result, we found four ORFs, two of which were confirmed to participate in the biosynthesis of copalyl diphosphate by in vitro studies, In this study, copalyl diphosphate was confirmed to be formed from GGDP by the ORF2 product although absolute stereochemistry of the product remains unclear.
anti-Copalyl diphosphate and ent-copalyl diphosphate are intermediates of abietadiene and ent-kaur-16-ene, respectively26). To estimate whether the ORF2 product might be an anti-CPS or ent-CPS, we compared amino acid similarities between the ORF2 product and the abietadiene synthase or ent-CPSs responsible for ent-kaur-16-ene biosynthesis. First, we compared the amino acid sequence of the ORF2 product with that of the N-terminal domain of abietadiene synthase because the N-terminal domain of abietadiene synthase was reported to catalyze a conversion of GGDP into anti-copalyl diphosphate28). By means of the amino acid sequence alignment programs FASTA and BLAST, the similarity between the two enzymes was 22% identity over 327 amino acids. On the other hand, the similarities between the ORF2 and ent-CPSs were almost the same as that between the ORF2 product and abietadiene synthase, such as ent-kaurene synthase from Gibberella fujikuroi29) (27% identity over 481 amino acids) and entkaurene synthase A (ent-CPS) from Pisum sativum30) (22% identity over 439 amino acids). Therefore, comparison of the amino acid sequence of these enzymes did not give any clue as to whether the ORF2 product is an anti-CPS or ent-
CPS.
In contrast, the most homologous protein to the ORF2 product was the Cyc1 (36% identity over 499 amino acids), 
